Bristol-Myers Squibb Company (BMY)

BMY Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	11,464	9,123	13,979	14,546	12,346
Short-Term Investments	816	130	2,987	1,285	3,047
Cash & Cash Equivalents	12,280	9,253	16,966	15,831	15,393
Cash Growth	32.71%	-45.46%	7.17%	2.85%	75.74%
Receivables	10,921	9,886	9,369	8,501	7,685
Inventory	2,662	2,339	2,095	2,074	4,293
Other Current Assets	5,907	5,795	4,832	3,786	1,983
Total Current Assets	31,770	27,273	33,262	30,192	29,354
Property, Plant & Equipment	6,646	6,255	6,049	5,886	6,252
Long-Term Investments	364	0	0	433	767
Goodwill and Intangibles	48,241	57,008	63,029	73,790	86,457
Other Long-Term Assets	8,138	6,284	6,974	8,180	7,114
Total Long-Term Assets	63,389	69,547	76,052	88,289	100,590
Total Assets	95,159	96,820	109,314	118,481	129,944
Accounts Payable	3,259	3,040	2,949	2,713	2,445
Current Debt	3,119	4,264	4,948	2,340	3,346
Other Current Liabilities	15,884	14,586	13,971	14,027	12,513
Total Current Liabilities	22,262	21,890	21,868	19,080	18,304
Long-Term Debt	36,653	35,056	39,605	48,336	43,387
Other Long-Term Liabilities	6,759	8,756	11,835	13,183	16,555
Total Long-Term Liabilities	43,412	43,812	51,440	61,519	59,942
Total Liabilities	65,674	65,702	73,308	80,599	78,246
Total Debt	39,772	39,320	44,553	50,676	46,733
Debt Growth	1.15%	-11.75%	-12.08%	8.44%	535.91%
Retained Earnings	28,766	25,503	23,820	21,281	34,474
Comprehensive Income	-1,546	-1,281	-1,268	-1,839	-1,520
Shareholders' Equity	29,430	31,061	35,946	37,822	51,598
Net Cash / Debt	-27,492	-30,067	-27,587	-34,845	-31,340
Working Capital	9,508	5,383	11,394	11,112	11,050
Book Value Per Share	14.46	14.61	16.19	16.74	31.67

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).